Drug intelligence / Profile preview

Oxyvision

Development stage
Unknown
Lead developer
Eyekare Kilitch
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Oxyvision is an oral nutraceutical tablet developed by Eyekare Kilitch to support overall eye health and assist in the management of conditions like glaucoma. The formulation contains a combination of natural antioxidants and essential nutrients, including bilberry extract, pine bark extract, lutein, astaxanthin, zeaxanthin, and essential vitamins and minerals (such as vitamins A, C, and E, zinc, copper, and selenium). These ingredients work synergistically to reduce intraocular pressure, improve blood vessel lining, decrease capillary permeability, and protect ocular tissues from oxidative stress and inflammation.

Brand names
OxivisionOxyvision
Other names
Bilberry Extract, Pine Bark, Lutein, Astaxanthin, Zeaxanthin with Essential Vitamins & Minerals

Beyond the preview

Go deeper on Oxyvision.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxyvision.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call